Core Viewpoint - Rosen Law Firm is reminding investors who purchased Reddit, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on August 18, 2025, and the potential for compensation without out-of-pocket costs [1][2]. Group 1: Class Action Details - A class action lawsuit has been filed against Reddit, Inc. for allegedly making false and misleading statements regarding user engagement and advertising revenues during the Class Period [4]. - The lawsuit claims that changes in Google Search's algorithm led to a significant reduction in traffic to Reddit, which was not disclosed by the defendants [4]. - Investors are encouraged to join the class action by contacting Rosen Law Firm for more information [2][5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3]. - Founding partner Laurence Rosen has been recognized as a Titan of Plaintiffs' Bar by Law360, highlighting the firm's expertise in this area [3].

Core Insights - Vanguard Information Technology Index Fund ETF (NYSEARCA: VGT) is one of the largest technology ETFs in the market, with assets under management totaling $114.89 billion [1] Group 1 - The fund received a hold rating in late April, coinciding with market trends [1] - The author emphasizes a focus on macroeconomic analysis and aims to equip investors with tools for informed decision-making [1] Group 2 - The article does not provide specific investment recommendations or advice regarding suitability for individual investors [2] - It highlights that past performance is not indicative of future results [2]

Resideo Technologies, Inc. REZI ended its long-standing Honeywell International Inc. HON indemnification with a $1.59 billion buyout, removing a major overhang and clearing the way for cleaner earnings and an ADI Global separation.Morgan Stanley analyst Erik W Woodring upgraded Resideo from Equal-weight to Overweight, raising the price forecast from $24 to $35.Woodring laid out a three-part case. The analyst said Resideo continues to execute, with second quarter above the high end of guidance, the strongest ...

Group 1 - Cognex Corporation (NASDAQ: CGNX) is positioned to benefit from a strong market as the U.S. attracts over $1 trillion in foreign investments aimed at reindustrialization [1] - New trade deals are facilitating significant outside investments into the U.S., enhancing the market environment for companies like Cognex [1] Group 2 - The analyst, Michael Del Monte, has over 5 years of experience in equity analysis and has worked across various industries including Oil & Gas, Information Technology, and Industrials [1]

Core Insights - Surmodics, Inc. (SRDX) reported adjusted earnings per share (EPS) of 6 cents for Q3 fiscal 2025, a significant improvement from a loss of 27 cents in the same quarter last year and better than the Zacks Consensus Estimate of a loss of 21 cents [1] - The company’s total revenues for the quarter were $29.6 million, reflecting a year-over-year decline of 2.6%, but exceeding the Zacks Consensus Estimate by 4.3% [2][4] - Surmodics has revised its fiscal 2025 revenue guidance, now expecting total revenues between $116.5 million and $118.5 million, which indicates a decrease of 8-6% compared to the previous fiscal year [12][13] Revenue Analysis - Total revenues included $0.0 million from SurVeil drug-coated balloon (DCB) license fees, down from $1.1 million in Q3 fiscal 2024, attributed to the completion of the TRANSCEND clinical trial [2][4] - Excluding SurVeil DCB license fees, total revenues increased by 1% year-over-year to $29.6 million [3] - The Medical Device segment reported sales of $22.2 million, a decrease of 4.9% from the previous year, while In Vitro Diagnostics (IVD) sales improved by 5.7% to $7.4 million [5][6] Segment Performance - Product sales were $16.8 million, down 4.6% year-over-year, while royalties and license fees totaled $9.7 million, a decline of 7.7% [7] - Research, development, and other revenues increased by 35.7% to $3.1 million [8] - The decrease in SurVeil DCB product sales revenues was $1.7 million year-over-year, primarily due to lower demand from Abbott, Surmodics' exclusive distribution partner [4] Margin and Expense Trends - Gross profit decreased by 4.1% year-over-year to $20.9 million, with a gross margin contraction of 116 basis points to 70.9% [9] - Selling, general, and administrative expenses rose by 6.8% to $17.8 million, while research and development expenses fell by 22.4% to $7.6 million [10] Financial Position - Surmodics ended Q3 fiscal 2025 with cash and cash equivalents of $26.3 million, down from $29.2 million at the end of the previous quarter [11] - Total long-term debt slightly increased to $29.67 million from $29.63 million [11] Future Guidance - The company anticipates a decrease of $3.6 million in SurVeil DCB license fee revenues for fiscal 2025, with no further recognition of these revenues after March 31, 2025 [14] - Adjusted loss per share for fiscal 2025 is now projected to be between 35 and 20 cents, an improvement from the previous outlook of 62 to 42 cents [15]

Core Insights - Kratos Defense & Security Solutions, Inc. (KTOS) is expanding its presence in the defense technologies sector through its Kratos Government Solutions (KGS) segment, which offers advanced systems supporting U.S. and allied military missions [1][4] - KGS provides secure communication networks and advanced satellite ground systems, essential for intelligence, surveillance, and reconnaissance operations, and is involved in hypersonic technology development [2][3] - The recent acquisition of assets from Norden Millimeter, Inc. has enhanced KGS's microwave and Radio Frequency capabilities, strengthening its defense solutions [3][8] Financial Performance - In Q2 2025, KGS revenues increased by 29.9% year-over-year to $278.3 million, driven by growth across all business areas and the benefits from the Norden acquisition [4][8] - KTOS shares have appreciated by 229.7% over the past year, significantly outperforming the industry average growth of 45.8% [7] Market Position and Valuation - KTOS shares are currently trading at a relative discount, with a forward 12-month Price/Sales ratio of 7.12X compared to the industry average of 10.13X [9] - The Zacks Consensus Estimate for KTOS's third-quarter 2025 earnings has declined in the past 60 days, while the fourth-quarter estimate remains unchanged [10]

Group 1 - Kodak has announced "substantial doubt" about its ability to continue operations, as stated in a recent SEC filing [1][3] - The company plans to address its financial obligations by utilizing funds expected from its pension plan, aiming to pay off some debt and preferred stock [2] - Kodak's plans to refinance its remaining debt and preferred stock obligations are considered unreliable under U.S. accounting rules, raising concerns about its business viability [3] Group 2 - Kodak was a pioneer in film photography, dominating the market for much of the 20th century and controlling over 80% of the U.S. film market at its peak [5] - The company's failure to adapt to digital photography led to the collapse of its core business, struggling against competitors like Canon, Sony, and Nikon [8] - After filing for bankruptcy in 2012, Kodak emerged in 2013 but has not regained its former market dominance, shifting focus to commercial printing and technology [11]

Core Points - PennantPark Investment Corporation held its Q3 2025 earnings conference call on August 12, 2025, with key participants including the CEO and CFO [1][2][3] - The call was initiated by the CEO, Arthur Howard Penn, who welcomed participants and introduced the CFO for further disclosures [3][4] Company Information - The conference call was recorded and is considered the property of PennantPark Investment Corporation, with an audio replay available on the company's website [4] - The CFO, Richard Thomas Allorto, provided general information about the call and mentioned the customary safe harbor disclosure regarding forward-looking statements [4][5]

Key Takeaways AAL to launch six new routes to Europe and South America in summer 2026.New service includes the sole nonstop U.S.-Budapest route and expanded Buenos Aires flights.Premium seating to Tokyo from Dallas and Los Angeles is expected to rise over 45% year over year.In a bid to attract additional traffic, American Airlines (AAL) has decided to expand its international network. To this end, AAL announced six new routes to Europe and South America for travelers to experience in summer 2026. As part of ...

Key Takeaways MAC posted Q2 FFO of $0.32, missing estimates and down from $0.44 last-year quarter.Q2 revenues rose 15.9% year over year to $249.8 million, beating consensus estimates.Leased square footage signed increased Y/Y, driving higher NOI and base rent re-leasing spreads.The Macerich Company (MAC) reported second-quarter 2025 funds from operations (FFO) per share of 32 cents, missing the Zacks Consensus Estimate of 34 cents. The reported figure compares unfavorably with the prior-year quarter’s 44 ce ...